Hot topics this week include clinical trial data, the new weight management drug Contrave, and good news for those suffering with rheumatoid arthritis!

1.  NICE to Seek Greater Access to Clinical Trial Data  NICE (National Institute for Health and Care Excellence) will ask the European regulatory authorities for access to clinical trial data if relevant data is not supplied by pharmaceutical companies.

Contrave for obesity2.  FDA approves weight-management drug Contrave  Contrave is only the third obesity treatment that the FDA has approved in the past two years.

3.  Blocking One Receptor On Cells Could Halt Rheumatoid Arthritis  Researchers show all that is required to slow inflammation and bone degradation of rheumatoid arthritis is the activation of one receptor.